2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate

C46H36Cl2N12O8Os2 — CID 139166550

IUPAC2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate
SMILES[O-][Cl+3]([O-])([O-])[O-].[O-][Cl+3]([O-])([O-])[O-].[Os+2].[Os+2].c1c[n-]c(-c2ncc[n-]2)n1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1
InChIInChI=1S/4C10H8N2.C6H4N4.2ClHO4.2Os/c4*1-3-7-11-9(5-1)10-6-2-4-8-12-10;1-2-8-5(7-1)6-9-3-4-10-6;2*2-1(3,4)5;;/h4*1-8H;1-4H;2*(H,2,3,4,5);;/q;;;;-2;;;2*+2/p-2
InChIKeyZLWONJJNNSBNCN-UHFFFAOYSA-L
MW1336.24 g/mol
LogP-0.88
Rot. Bonds5

About 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate

2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate (PubChem CID 139166550) has the molecular formula C46H36Cl2N12O8Os2 and a molecular weight of 1336.24 g/mol. Its IUPAC name is 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate.

Molecular Properties

Compound Name2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate
PubChem CID139166550
Molecular FormulaC46H36Cl2N12O8Os2
Molecular Weight1336.24 g/mol
Exact Mass1338.14
IUPAC Name2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate
SMILES[O-][Cl+3]([O-])([O-])[O-].[O-][Cl+3]([O-])([O-])[O-].[Os+2].[Os+2].c1c[n-]c(-c2ncc[n-]2)n1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1
InChIInChI=1S/4C10H8N2.C6H4N4.2ClHO4.2Os/c4*1-3-7-11-9(5-1)10-6-2-4-8-12-10;1-2-8-5(7-1)6-9-3-4-10-6;2*2-1(3,4)5;;/h4*1-8H;1-4H;2*(H,2,3,4,5);;/q;;;;-2;;;2*+2/p-2
InChIKeyZLWONJJNNSBNCN-UHFFFAOYSA-L
XLogP-0.88
TPSA341.58 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds5
Heavy Atoms70
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001336.24
LogP ≤ 5-0.88
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate?
The IUPAC name of 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate (CID 139166550) is 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate.
What is the SMILES notation for 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate?
The canonical SMILES for 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate is [O-][Cl+3]([O-])([O-])[O-].[O-][Cl+3]([O-])([O-])[O-].[Os+2].[Os+2].c1c[n-]c(-c2ncc[n-]2)n1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2ccccn2)nc1.
What is the InChIKey of 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate?
The InChIKey is ZLWONJJNNSBNCN-UHFFFAOYSA-L. The full InChI is InChI=1S/4C10H8N2.C6H4N4.2ClHO4.2Os/c4*1-3-7-11-9(5-1)10-6-2-4-8-12-10;1-2-8-5(7-1)6-9-3-4-10-6;2*2-1(3,4)5;;/h4*1-8H;1-4H;2*(H,2,3,4,5);;/q;;;;-2;;;2*+2/p-2.
What are the key properties of 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate?
2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate has a molecular weight of 1336.24 g/mol, XLogP of -0.88, 5 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-imidazol-3-id-2-ylimidazol-3-ide;bis(osmium(2+));tetrakis(2-pyridin-2-ylpyridine);diperchlorate is sourced from PubChem (CID 139166550), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).